White House Awaits FDA Decision on Moderna COVID Vaccine for Young Children

Published on May 22, 2022

The White House is eagerly awaiting a decision from the U.S. Food and Drug Administration (FDA) regarding the authorization of Moderna’s COVID-19 vaccine for children under the age of five. Dr. Ashish Jha, the White House COVID-19 response coordinator, anticipates that this decision will be made in the coming weeks. Just as a young bird waits for its parents to bring it food, the White House is eagerly waiting for the FDA to determine the safety and efficacy of Moderna’s vaccine for this age group. If approved, the availability of a vaccine specifically designed for young children will greatly contribute to the ongoing efforts to curb the spread of COVID-19. As we wait for this decision, it is important to remember that vaccines undergo rigorous testing and scrutiny to ensure their safety and effectiveness. Curious minds can dive deeper into the research behind this decision by exploring the official reports and documentation released by the FDA and Moderna.

White House COVID-19 response coordinator Dr. Ashish Jha said on Sunday he expects a U.S. Food and Drug Administration decision on authorizing Moderna’s vaccine for children under age five within the next few weeks.
Moderna completed its application and FDA experts are…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>